You can meet and interact with AKESOgen at the following events.
AKESOgen exhibited and presented at the American Society of Human Genetics 2016 Annual Meeting in Vancouver, Canada, October 18th – 22nd.
Dr. Bouzyk presented novel genotyping solutions for large scale genotyping studies. We invite you learn more about our genomics solutions in:
- Research Services
- Clinical Diagnostics Services
- Clinical Trials Services
by contacting us at 770 542 0890 or emailing email@example.com
March 1st, 2016 – Dr. Mark Bouzyk, CSO of AKESOgen, has been invited to the SWALEC stadium in Cardiff, U.K for the Cancer Research Wales 50th anniversary. March 1st commemorates St. David’s day, a national day of celebration within Wales. Cancer Research Wales will be showcasing its milestones and research achievements over the last 50 years with the theme of the symposium is “Cancer Research Wales at 50 Working Towards Precision Medicine.” The symposium will bring together top cancer scientists and clinicians from across Wales and the UK giving them an opportunity to discuss and share their latest findings but also plan future collaborations.
AKESOgen makes Annual List of America’s Fastest-Growing Private Companies—the Inc.500
AKESOgen Ranks as the No. 44 Healthcare Company and 363rd Overall on the 2015 Inc.500 with Three-Year Sales Growth of 1,300%
NEW YORK and ATLANTA, August 12, 2015 — Inc. magazine today ranked the genomics services provider, AKESOgen, 44th as a Healthcare company and 363rd overall on its 34th annual Inc.500|5000, an exclusive ranking of the nation’s fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economy—America’s independent entrepreneurs. Companies such as Intuit, Zappos, Under Armour, Microsoft, GoPro, Timberland, Clif Bar, Patagonia, Oracle, and many other well-known names gained early exposure as members of the Inc.500|5000.
“We are delighted to be recognized as an Inc.500 honoree with such well known organizations in 2015 as Fitbit, Smashburger, Bowlmor AMF, Planet Fitness, Giftcards.com, Radio Flyer, Box, and Mindbody.” commented AKESOgen CEO Robert Boisjoli.
“Genetics and Precision Medicine are becoming more and more pervasive in our society. As a result, there is an unprecedented need for genomics capabilities in clinical trials and diagnostics, in addition to research. AKESOgen is at the forefront of providing these molecular technologies for 21st century personalized medicine.” says Mark Bouzyk, AKESOgen’s CSO.
This year’s crop of Inc.500 companies is the most competitive in the list’s history. “For 34 years, Inc. has welcomed the fastest-growing companies in America into a very exclusive club. To make it among the top 500 companies on the list, honorees had to have grown at least tenfold over the past three years. That’s a result most businesses could only dream of…” says Inc. President and Editor-In-Chief Eric Schurenberg.
Complete results of the Inc.500|5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at www.inc.com/inc500.
About Inc. Magazine
Founded in 1979 and acquired in 2005 by Mansueto Ventures, Inc. Magazine is the only major brand dedicated exclusively to owners and managers of growing private companies. Total monthly audience reach for the brand has reached over 6,000,000 in 2015. For more information, visit www.inc.com
About AKESOgen, Inc.
AKESOgen is an integrated genomics, genetics and bio-banking company that services the pharmaceutical, biotechnology, clinical, academic, and government sectors for clinical trials, diagnostic clinical testing, and research. Based in Atlanta USA, the company’s main focus is oncology and personalized medicine. AKESOgen’s services include providing high-throughput, biomarker profiling, cytogenetic arrays, sequencing, and genomics analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, and methylation) to CLIA/GLP standards. For more information, visit www.akesogen.com
Crystal Yang, Client Relations Specialist, Scientific Affairs, AKESOgen, Inc. +1 770-542-0890 ext 101 (office), or firstname.lastname@example.orgShare this
AKESOgen scientists to attend the third ICB conference in Shanghai, China from October 17-18, 2015. AKESOgen’s CSO, Mark Bouzyk, has been invited to speak as a leading expert on genomic profiling in multiple cancers, specifically towards Precision Medicine.
Please email email@example.com or call 770 542 0890 if you want to schedule an appointment with a delegate or to discuss your genomics needs.Share this
Please join Georgia Bio’s Emerging Leaders Network on their Industry Tour for an inside look of AKESOgen, a premier provider of genetic analysis.
This industry tour will provide participants an inside look of AKESOgen, a leader in personalized medicine and genomics. Equipped with industry experts, AKESOgen provides high quality genomic analysis services, performing over 21,000 whole genome genotyping monthly. It is the only facility in the United States that has developed and performs clinical commercial copy number alteration (CNA) microarray analysis for formalin-fixed, paraffin-embedded (FFPE) tissue samples on Illumina platforms. AKESOgen provides contract research, clinical diagnostic and clinical trial services to pharmaceutical, biotech, academic, and government research institutions. The company supported over 100 academic investigators in 2014.
All participants should be dressed smart casual with closed toe shoes.
To register for this event and further details please go to: http://www.gabio.org/events/event_details.asp?id=600212
Wednesday, September 09, 2015
10:30 am – 12:30 pm